Resveratrol impairs the release of steroid-resistant inflammatory cytokines from human airway smooth muscle cells in chronic obstructive pulmonary disease

Journal of Pharmacology and Experimental Therapeutics

Volumn 335, Issue 3, 2010, Pages 788-798

  Knobloch, Jürgen ^a   Sibbing, Bernhard ^a   Jungck, David ^a   Lin, Yingfeng ^a   Urban, Katja ^a   Stoelben, Erich ^b   Strauch, Justus ^a   Koch, Andrea ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b Lungenklinik Merheim   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE P38; RESVERATROL; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BRONCHI; CELLS, CULTURED; CYTOKINES; DEXAMETHASONE; FEMALE; GENE EXPRESSION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-8; MALE; MIDDLE AGED; MYOCYTES, SMOOTH MUSCLE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASE INHIBITORS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY SYSTEM; SMOKING; STILBENES; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 78649532744     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.110.166843     Document Type: Article

References (36)

1. Adcock IM and Barnes PJ (2008) Molecular mechanisms of corticosteroid resistance. Chest 134:394-401.
2. Armstrong J, Sargent C, and Singh D (2009) Glucocorticoid sensitivity of lipopolysaccharide-stimulated chronic obstructive pulmonary disease alveolar macrophages. Clin Exp Immunol 158:74-83.
3. Barnes PJ (2004) Alveolar macrophages as orchestrators of COPD. COPD 1:59-70.
4. Barnes PJ (2008a) Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol 8:183-192. (Pubitemid 351323287)
5. Barnes PJ (2008b) Future treatments for chronic obstructive pulmonary disease and its comorbidities. Proc Am Thorac Soc 5:857-864.
6. Barnes PJ and Adcock IM (2009) Glucocorticoid resistance in inflammatory diseases. Lancet 373:1905-1917.
7. Bhat KP and Pezzuto JM (2002) Cancer chemopreventive activity of resveratrol. Ann NY Acad Sci 957:210-229.
8. Cottart CH, Nivet-Antoine V, Laguillier-Morizot C, and Beaudeux JL (2010) Resveratrol bioavailability and toxicity in humans. Mol Nutr Food Res 54:7-16.
9. Culpitt SV, Rogers DF, Fenwick PS, Shah P, De Matos C, Russell RE, Barnes PJ, and Donnelly LE (2003a) Inhibition by red wine extract, resveratrol, of cytokine release by alveolar macrophages in COPD. Thorax 58:942-946. (Pubitemid 37392803)
10. Culpitt SV, Rogers DF, Shah P, De Matos C, Russell RE, Donnelly LE, and Barnes PJ (2003b) Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 167:24-31. (Pubitemid 36015913)
11. Elliott PJ and Jirousek M (2008) Sirtuins: novel targets for metabolic disease. Curr Opin Investig Drugs 9:371-378.
12. Fabbri L, Pauwels RA, Hurd SS, and GOLD Scientific Committee (2004) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary updated 2003. COPD 1:105-141; discussion 103-104.
13. Hazzalin CA, Le Panse R, Cano E, and Mahadevan LC (1998) Anisomycin selectively desensitizes signalling components involved in stress kinase activation and fos and jun induction. Mol Cell Biol 18:1844-1854.
14. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, et al. (2004) The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 350:2645-2653.
15. Ito K and Barnes PJ (2009) COPD as a disease of accelerated lung aging. Chest 135:173-180.
16. Ito K, Yamamura S, Essilfie-Quaye S, Cosio B, Ito M, Barnes PJ, and Adcock IM (2006) Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-κB suppression. J Exp Med 203:7-13.
17. John M, Au BT, Jose PJ, Lim S, Saunders M, Barnes PJ, Mitchell JA, Belvisi MG, and Chung KF (1998) Expression and release of interleukin-8 by human airway smooth muscle cells: inhibition by Th-2 cytokines and corticosteroids. Am J Respir Cell Mol Biol 18:84-90.
18. Kanazawa H (2007) Role of vascular endothelial growth factor in the pathogenesis of chronic obstructive pulmonary disease. Med Sci Monit 13:RA189-RA195.
19. Kasahara Y, Tuder RM, Taraseviciene-Stewart L, Le Cras TD, Abman S, Hirth PK, Waltenberger J, and Voelkel NF (2000) Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest 106:1311-1319.
20. Knobloch J, Peters H, Jungck D, Müller K, Strauch J, and Koch A (2009) TNFα-induced GM-CSF release from human airway smooth muscle cells depends on activation of an ET-1 autoregulatory positive feedback mechanism. Thorax 64: 1044-1052.
21. Knobloch J, Shaughnessy JD Jr, and Rüther U (2007) Thalidomide induces limb deformities by perturbing the Bmp/Dkk1/Wnt signaling pathway. FASEB J 21: 1410-1421.
22. Koch A, Giembycz M, Ito K, Lim S, Jazrawi E, Barnes PJ, Adcock I, Erdmann E, and Chung KF (2004a) Mitogen-activated protein kinase modulation of nuclear factor-κB-induced granulocyte macrophage-colony-stimulating factor release from human alveolar macrophages. Am J Respir Cell Mol Biol 30:342-349.
23. Koch A, Giembycz M, Stirling RG, Lim S, Adcock I, Wassermann K, Erdmann E, and Chung KF (2004b) Effect of smoking on MAP kinase-induced modulation of IL-8 in human alveolar macrophages. Eur Respir J 23:805-812.
24. Marwick JA, Stevenson CS, Giddings J, MacNee W, Butler K, Rahman I, and Kirkham PA (2006) Cigarette smoke disrupts VEGF165-VEGFR-2 receptor signaling complex in rat lungs and patients with COPD: morphological impact of VEGFR-2 inhibition. Am J Physiol Lung Cell Mol Physiol 290:L897-L908.
25. Mullan CS, Riley M, Clarke D, Tatler A, Sutcliffe A, Knox AJ, and Pang L (2008) Beta-tryptase regulates IL-8 expression in airway smooth muscle cells by a PAR-2-independent mechanism. Am J Respir Cell Mol Biol 38:600-608.
26. Munoz L, Ramsay EE, Manetsch M, Ge Q, Peifer C, Laufer S, and Ammit AJ (2010) Novel p38 MAPK inhibitor ML3403 has potent anti-inflammatory activity in airway smooth muscle. Eur J Pharmacol 635:212-218.
27. Pang L and Knox AJ (2000) Synergistic inhibition by β(2)-agonists and corticosteroids on tumor necrosis factor-α-induced interleukin-8 release from cultured human airway smooth-muscle cells. Am J Respir Cell Mol Biol 23:79-85.
28. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS, and GOLD Scientific Committee (2001) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 163:1256-1276.
29. Pervaiz S and Holme AL (2009) Resveratrol: its biologic targets and functional activity. Antioxid Redox Signal 11:2851-2897.
30. Rahman I (2008) Antioxidant therapeutic advances in COPD. Ther Adv Respir Dis 2:351-374.
31. Raidl M, Sibbing B, Strauch J, Müller K, Nemat A, Schneider PM, Hag H, Erdmann E, and Koch A (2007) Impaired TNFα-induced VEGF expression in human airway smooth muscle cells from smokers with COPD: role of MAP kinases and histone acetylation-effect of dexamethasone. Cell Biochem Biophys 49:98-110.
32. Saunders MA, Mitchell JA, Seldon PM, Yacoub MH, Barnes PJ, Giembycz MA, and Belvisi MG (1997) Release of granulocyte-macrophage colony stimulating factor by human cultured airway smooth muscle cells: suppression by dexamethasone. Br J Pharmacol 120:545-546.
33. Shan X, Hu A, Veler H, Fatma S, Grunstein JS, Chuang S, and Grunstein MM(2006) Regulation of Toll-like receptor 4-induced proasthmatic changes in airway smooth muscle function by opposing actions of ERK1/2 and p38 MAPK signaling. Am J Physiol Lung Cell Mol Physiol 291:L324-L333.
34. Tliba O, Amrani Y, and Panettieri RA Jr (2008) Is airway smooth muscle the "missing link" modulating airway inflammation in asthma? Chest 133:236-242.
35. Tuder RM and Yun JH (2008) Vascular endothelial growth factor of the lung: friend or foe. Curr Opin Pharmacol 8:255-260.
36. Whyte L, Huang YY, Torres K, and Mehta RG (2007) Molecular mechanisms of resveratrol action in lung cancer cells using dual protein and microarray analyses. Cancer Res 67:12007-12017.